Lily Proctor

552 total citations
15 papers, 348 citations indexed

About

Lily Proctor is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Lily Proctor has authored 15 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Surgery and 6 papers in Oncology. Recurrent topics in Lily Proctor's work include Cervical Cancer and HPV Research (13 papers), Global Cancer Incidence and Screening (4 papers) and Colorectal and Anal Carcinomas (4 papers). Lily Proctor is often cited by papers focused on Cervical Cancer and HPV Research (13 papers), Global Cancer Incidence and Screening (4 papers) and Colorectal and Anal Carcinomas (4 papers). Lily Proctor collaborates with scholars based in Canada, United States and United Kingdom. Lily Proctor's co-authors include C. Blake Gilks, David G. Huntsman, Jessica N. McAlpine, Emily F. Thompson, Basile Tessier‐Cloutier, Lynn Hoang, Jennifer Pors, Julie Ho, Leah Prentice and Melissa K. McConechy and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and The American Journal of Surgical Pathology.

In The Last Decade

Lily Proctor

14 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lily Proctor Canada 9 190 184 88 86 80 15 348
Jackie Jamison United Kingdom 10 177 0.9× 216 1.2× 89 1.0× 65 0.8× 163 2.0× 18 405
Fani Kokka United Kingdom 9 140 0.7× 163 0.9× 128 1.5× 71 0.8× 249 3.1× 14 428
Suchanan Hanamornroongruang Thailand 10 82 0.4× 110 0.6× 158 1.8× 56 0.7× 94 1.2× 29 358
Linda S. Nooij Netherlands 10 311 1.6× 354 1.9× 47 0.5× 133 1.5× 164 2.0× 20 527
Enzo Ricciardi Italy 13 88 0.5× 71 0.4× 145 1.6× 43 0.5× 155 1.9× 24 319
L.-C. Horn Germany 9 98 0.5× 80 0.4× 107 1.2× 43 0.5× 142 1.8× 35 296
B. Bolger United Kingdom 10 102 0.5× 189 1.0× 75 0.9× 85 1.0× 125 1.6× 11 366
Yun‐Hsin Tang Taiwan 12 69 0.4× 139 0.8× 176 2.0× 58 0.7× 183 2.3× 29 393
Nicolas M. Monte United States 6 77 0.4× 88 0.5× 185 2.1× 34 0.4× 153 1.9× 8 361
Cristina Terinte Romania 10 209 1.1× 346 1.9× 139 1.6× 77 0.9× 365 4.6× 31 590

Countries citing papers authored by Lily Proctor

Since Specialization
Citations

This map shows the geographic impact of Lily Proctor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Proctor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Proctor more than expected).

Fields of papers citing papers by Lily Proctor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Proctor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Proctor. The network helps show where Lily Proctor may publish in the future.

Co-authorship network of co-authors of Lily Proctor

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Proctor. A scholar is included among the top collaborators of Lily Proctor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Proctor. Lily Proctor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gottschlich, Anna, Quan Hong, Lovedeep Gondara, et al.. (2024). Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 33(7). 904–911. 1 indexed citations
2.
Gottschlich, Anna, Laurie Smith, Lily Proctor, & Gina Ogilvie. (2024). HPV Extended Genotyping to Triage Abnormal Cervical Cancer Screens—Balancing the Harms and Benefits of an Additional Triage Test before Direct Colposcopy Referral. Cancer Epidemiology Biomarkers & Prevention. 33(8). 979–981.
3.
Pataky, Reka, Sara Izadi‐Najafabadi, Laurie Smith, et al.. (2024). Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study. Canadian Medical Association Journal. 196(21). E716–E723. 2 indexed citations
4.
Gottschlich, Anna, Lovedeep Gondara, Laurie Smith, et al.. (2023). Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study. The Lancet Regional Health - Americas. 26. 100598–100598. 3 indexed citations
5.
Willows, Karla, Amanda Selk, Marie-Hélène Auclair, et al.. (2023). 2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia. Current Oncology. 30(6). 5738–5768. 9 indexed citations
6.
Gottschlich, Anna, Lovedeep Gondara, Laurie Smith, et al.. (2022). Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial. International Journal of Cancer. 151(6). 897–905. 9 indexed citations
7.
Jamieson, Amy, et al.. (2022). A Scoping Review of Treatment Outcome Measures for Vulvar Intraepithelial Neoplasia. Journal of Lower Genital Tract Disease. 26(4). 328–338. 1 indexed citations
8.
Tessier‐Cloutier, Basile, Jennifer Pors, Emily F. Thompson, et al.. (2020). Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome. Modern Pathology. 34(2). 508–518. 46 indexed citations
9.
Tessier‐Cloutier, Basile, Kim E. Kortekaas, Emily F. Thompson, et al.. (2020). Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status. Modern Pathology. 33(8). 1595–1605. 118 indexed citations
10.
Thompson, Emily F., Julia Chen, Jutta Huvila, et al.. (2020). p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns. Modern Pathology. 33(9). 1649–1659. 30 indexed citations
11.
Proctor, Lily, Lien Hoang, Emily F. Thompson, et al.. (2019). Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma. International Journal of Gynecological Cancer. 30(1). 100–106. 34 indexed citations
12.
Proctor, Lily, Troy Grennan, Arianne Albert, et al.. (2019). Screening for Anal Cancer in Women With a History of Vulvar High-Grade Squamous Intraepithelial Lesions. Journal of Lower Genital Tract Disease. 23(4). 265–271. 9 indexed citations
13.
Karnezis, Anthony N., Yemin Wang, Basile Tessier‐Cloutier, et al.. (2019). DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors. The American Journal of Surgical Pathology. 43(5). 628–638. 61 indexed citations
14.
Silva, Dane A. De, et al.. (2017). Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia. PLoS ONE. 12(12). e0189966–e0189966. 6 indexed citations
15.
Proctor, Lily, Manohar Pradhan, Samuel Leung, et al.. (2017). Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer. Gynecologic Oncology. 146(3). 596–602. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026